Highlights • Significant reductions in oral diuretic use were observed, with an average reduction of 65% at 24 months after metabolic surgery. • Decrease in body mass index and total…
COVID-19 may predispose patients to cardiac injuries but whether COVID-19 infection affects the morphological features of coronary plaques to potentially influence the outcome of patients with coronary artery disease (CAD)…
Studies assessing the treatment of refractory no-reflow in patients with ST-elevation myocardial infarction (STEMI) are limited to clinical cases and pilot studies. This study aimed to evaluate the efficacy and…
The United Network for Organ Sharing (UNOS) adopted new criteria for the heart allocation score on October 18, 2018 to reflect the changing trends of candidates’ mortality while awaiting transplant….
Highlights • In a post hoc analysis of a recent Japanese clinical trial, more than half of the patients with acute coronary syndromes received anticoagulation with unfractionated heparin after percutaneous…
Clonal hematopoiesis of indeterminate potential (CHIP) is a common risk factor for hematologic malignancies and cardiovascular diseases. This study aimed to investigate the association between CHIP-related mutations and symptomatic heart…
Computed tomography (CTA)–derived fractional flow reserve (FFR CT ) guides the need for invasive coronary angiography (ICA). Late outcomes after FFR CT are reported in stable ischemic heart disease but…
Chronic total occlusions (CTOs) are frequent in patients with previous coronary artery bypass graft (CABG) surgery. Percutaneous coronary intervention (PCI) is the usual revascularization strategy. Whether or not the presence…
Because of its superior safety profile and improved outcomes, trans-radial percutaneous coronary intervention (TRI) has become the preferred access in percutaneous coronary intervention (PCI) of native coronary disease. This study…
This study aimed to report the 5-year outcomes from the ILLUMENATE Pivotal randomized controlled trial of the lower dose (2 µg/mm 2 ) Stellarex drug-coated balloon (DCB) (Philips, formerly Spectranetics…
